Evaluation of the genotypic prediction of HIV-1 coreceptor use versus a phenotypic assay and correlation with the virological response to maraviroc: The ANRS genotropism study

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 8, 2010, Pages 3335-3340

  Recordon Pinson, Patricia ^a   Soulié, Cathia ^b   Flandre, Philippe ^b   Descamps, Diane ^c   Lazrek, Mouna ^d   Charpentier, Charlotte ^e   Montes, Brigitte ^f   Trabaud, Mary Anne ^g   Cottalorda, Jacqueline ^h   Schneider, Véronique ⁱ   Morand Joubert, Laurence ^j   Tamalet, Catherine ^k   Desbois, Delphine ^l   Macé, Muriel ^m   Ferré, Virginie ⁿ   Vabret, Astrid ^o   Ruffault, Annick ^p   Pallier, Coralie ^q   Raymond, Stéphanie ^r   Izopet, Jacques ^r   Reynes, Jacques ^f   Marcelin, Anne Geneviève ^b   Masquelier, Bernard ^a   Recordon Pinson, P ^s   Fleury, H ^s   Masquelier, B ^s   Vabret, A ^s   Pallier, C ^s   Lazrek, M ^s   Andre, P ^s   Tardy, J C ^s   Trabaud, M A ^s   Tamalet, C ^s   Montes, B ^s   Segondy, M ^s   Ferre V ^s   Cottalorda, J ^s   Mace M ^s   Descamps, D ^s   Brun Vezinet F ^s   Si Mohammed, A ^e   Charpentier, C ^e   Desbois, D ^s   Dussaix, E ^s   Marcelin, A G ^s   Soulie C ^s   Calvez, V ^s   Flandre, F ^s   Morand Joubert, L ^s   Amiel, C ^s   Schneider, V ^s   Maillard, A ^s   Ruffault, A ^s   Izopet, J ^s   Nicot, F ^s   Delobel, P ^s   Raymond, S ^s   Morlat, P ^s   Louis, I ^s   Ragnaud, J M ^s   Neau, D ^s   Dupon, M ^s   Raymond, I ^s   Verdon, R ^s   Delfraissy, J F ^s   Yazdanpanah, Y ^s   Chidiac, C ^s   Cotte, L ^s   Poizot Martin, I ^s   Ravaut, I ^s   Reynes, J ^s   Raffi, F ^s   Durant, J ^s   Prazuck, T ^s   Yeni, P ^s   Weiss, L ^e   Vittecocq, D ^s   Katlama, C ^s   Girard, P M ^s   Pialoux, G ^s   Michelet, C ^s   Marchou, B ^s   more..

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f MONTPELLIER UNIVERSITY HOSPITAL   (France)

^g CROIX ROUSSE HOSPITAL   (France)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ HÔPITAL TENON   (France)

^j HÔPITAL SAINT ANTOINE   (France)

^k ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^l Section of Radiology   (France)

^m Laboratoire de Virologie   (France)

ⁿ NANTES UNIVERSITY HOSPITAL   (France)

^o CAEN UNIVERSITY HOSPITAL   (France)

^p RENNES UNIVERSITY HOSPITAL   (France)

^q BICÊTRE HOSPITAL   (France)

^r TOULOUSE UNIVERSITY HOSPITAL   (France)

^s HEGP ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MARAVIROC; VIRUS RNA;

ADULT; ARTICLE; BIOINFORMATICS; CD4 LYMPHOCYTE COUNT; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; VIRUS ENTRY; VIRUS LOAD; VIRUS MUTATION;

ADULT; CYCLOHEXANES; FEMALE; GENOTYPE; HIV ENVELOPE PROTEIN GP120; HIV FUSION INHIBITORS; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; RECEPTORS, CCR5; RECEPTORS, HIV; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; TRIAZOLES; TROPISM;

EID: 77955373370     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00148-10     Document Type: Article

References (18)

1. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
2. Berro, R., R. W. Sanders, M. Lu, P. J. Klasse, and J. P. Moore. 2009. Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry. PLoS Pathog. 5:e1000548.
3. Chueca, N., C. Garrido, M. Alvarez, E. Poveda, J. de Dios Luna, N. Zahonero, J. Hernandez-Quero, V. Soriano, C. Maroto, C. de Mendoza, and F. Garcia. 2009. Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools. J. Med. Virol. 81:763-767.
4. Coakley, E., C. J. Petropoulos, and J. M. Whitcomb. 2005. Assessing chemokine co-receptor usage in HIV. Curr. Opin. Infect. Dis. 18:9-15.
5. Dorr, P., M. Westby, S. Dobbs, P. Griffin, B. Irvine, M. Macartney, J. Mori, G. Rickett, C. Smith-Burchnell, C. Napier, R. Webster, D. Armour, D. Price, B. Stammen, A. Wood, and M. Perros. 2005. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob. Agents Chemother. 49:4721-4732.
6. Garrido, C., V. Roulet, N. Chueca, E. Poveda, A. Aguilera, K. Skrabal, N. Zahonero, S. Carlos, F. Garcia, J. L. Faudon, V. Soriano, and C. de Mendoza. 2008. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes. J. Clin. Microbiol. 46:887-891.
7. Gulick, R. M., J. Lalezari, J. Goodrich, N. Clumeck, E. DeJesus, A. Horban, J. Nadler, B. Clotet, A. Karlsson, M. Wohlfeiler, J. B. Montana, M. McHale, J. Sullivan, C. Ridgway, S. Felstead, M. W. Dunne, E. van der Ryst, and H. Mayer. 2008. Maraviroc for previously treated patients with R5 HIV-1 infection. N. Engl. J. Med. 359:1429-1441.
8. Hirsch, M. S., H. F. Gunthard, J. M. Schapiro, F. Brun-Vezinet, B. Clotet, S. M. Hammer, V. A. Johnson, D. R. Kuritzkes, J. W. Mellors, D. Pillay, P. G. Yeni, D. M. Jacobsen, and D. D. Richman. 2008. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-U.S.A. panel. Clin. Infect. Dis. 47:266-285.
9. Lengauer, T., O. Sander, S. Sierra, A. Thielen, and R. Kaiser. 2007. Bioinformatics prediction of HIV coreceptor usage. Nat. Biotechnol. 25:1407-1410.
10. Moyle, G. J., A. Wildfire, S. Mandalia, H. Mayer, J. Goodrich, J. Whitcomb, and B. G. Gazzard. 2005. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. J. Infect. Dis. 191:866-872.
11. Raymond, S., P. Delobel, M. Mavigner, M. Cazabat, C. Souyris, S. Encinas, P. Bruel, K. Sandres-Saune, B. Marchou, P. Massip, and J. Izopet. 2010. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. J. Clin. Virol. 47:126-130.
12. Raymond, S., P. Delobel, M. Mavigner, M. Cazabat, C. Souyris, S. Encinas, K. Sandres-Saune, C. Pasquier, B. Marchou, P. Massip, and J. Izopet. 2009. Genotypic prediction of human immunodeficiency virus type 1 CRF02-AG tropism. J. Clin. Microbiol. 47:2292-2294.
13. Raymond, S., P. Delobel, M. Mavigner, M. Cazabat, C. Souyris, K. Sandres-Saune, L. Cuzin, B. Marchou, P. Massip, and J. Izopet. 2008. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism. AIDS 22:F11-F16.
14. Raymond, S., P. Delobel, M. Mavigner, L. Ferradini, M. Cazabat, C. Souyris, K. Sandres-Saune, C. Pasquier, B. Marchou, P. Massip, and J. Izopet. 2010. Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses. J. Acquir. Immune Defic. Syndr. 53:167-175.
15. Soulie, C., I. Malet, S. Lambert-Niclot, R. Tubiana, M. Thevenin, A. Simon, R. Murphy, C. Katlama, V. Calvez, and A. G. Marcelin. 2008. Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients. AIDS 22:2212-2214.
16. Su, Z., R. M. Gulick, A. Krambrink, E. Coakley, M. D. Hughes, D. Han, C. Flexner, T. J. Wilkin, P. R. Skolnik, W. L. Greaves, D. R. Kuritzkes, and J. D. Reeves. 2009. Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS Clinical Trials Group A5211. J. Infect. Dis. 200:1724-1728.
17. Trouplin, V., F. Salvatori, F. Cappello, V. Obry, A. Brelot, N. Heveker, M. Alizon, G. Scarlatti, F. Clavel, and F. Mammano. 2001. Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J. Virol. 75:251-259.
18. Whitcomb, J. M., W. Huang, S. Fransen, K. Limoli, J. Toma, T. Wrin, C. Chappey, L. D. Kiss, E. E. Paxinos, and C. J. Petropoulos. 2007. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism. Antimicrob. Agents Chemother. 51:566-575.